PRGOHIGH SIGNALFINANCIAL10-K

PRGO experienced a catastrophic financial deterioration with operating income swinging from $112.9M profit to -$1.1B loss while cash reserves plummeted 68%.

This represents a fundamental business crisis requiring immediate investor attention, as the company burned through over $1.3B in cash while posting massive operational losses. The dramatic shift from profitability to billion-dollar losses, combined with severely depleted liquidity, raises serious questions about the company's financial stability and potential going concern issues.

Comparing 2026-02-26 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

PRGO's financial position collapsed dramatically, with operating performance swinging from $112.9M profit to -$1.1B loss while net losses deepened from -$171.8M to -$1.4B. Cash and equivalents were decimated, falling 68% from $1.9B to just $600.7M, while stockholders' equity eroded 32% and operating cash flow declined 34%. This represents a severe liquidity crisis combined with massive operational losses that fundamentally threatens the company's financial viability.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-1094%
$112.9M→-$1.1B

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-729.7%
-$171.8M→-$1.4B

Net income declined 729.7% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
-67.8%
$1.9B→$600.7M

Cash declined 67.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Operating Cash Flow
Cash Flow
-34.3%
$362.9M→$238.5M

Operating cash flow fell 34.3% — earnings quality concerns; investigate working capital changes and non-cash items.

Stockholders Equity
Balance Sheet
-32%
$4.3B→$2.9B

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Capital Expenditure
Cash Flow
-21%
$118.3M→$93.4M

Capex reduced 21% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

R&D Expense
P&L
-15%
$112.2M→$95.4M

R&D spending cut 15% — could signal cost discipline or concerning reduction in innovation investment.

Current Assets
Balance Sheet
+12.7%
$2.5B→$2.8B

Current assets grew 12.7% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
-11.5%
$9.6B→$8.5B

Total assets contracted 11.5% — asset sales, write-downs, or balance sheet optimization underway.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-28
ADDED
As of February 24, 2026, the registrant had 137,649,352 outstanding ordinary shares.
Exhibits and Financial Statement Schedules 126 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this report are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and are subject to the safe harbor created thereby.
We have based these forward-looking statements on our current expectations, assumptions, estimates and projections.
Perrigo works to fulfill its vision and purpose as a top-tier consumer self-care company with a focused portfolio based on consumer-led innovation, which meets societal needs for: Access : Perrigo's self-care products and solutions enhance the daily lives of millions of families, empowering them to take control of their health and wellness.
Value : Perrigo delivers value by helping consumers proactively manage their well-being through affordable and effective self-care solutions.
+7 more — sign up free →
REMOVED
As of February 21, 2025, the registrant had 136,458,620 outstanding ordinary shares.
The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.
In Europe, our portfolio consists primarily of brands, including Compeed , EllaOne , Solpadeine , and ACO .
Two key initiatives are fundamental to advancing our self-care strategy our Supply Chain Reinvention Program, a global supply chain efficiency program, and Project Energize, a global investment and efficiency program.
Strategy Competitive Advantage Our objective is to grow our business by responsibly leveraging our global infrastructure to deliver high quality self-care solutions to customers and consumers through our expansive product offerings, providing new innovative products, brands, and product line extensions to existing consumers and servicing new consumers through entering new adjacent products and categories, new geographies and new channels of distribution organically and inorganically.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →